The clinical significance of plasma endothelin-1 in venous and portal blood of patients with portal hypertension

To investigate the significance of endothelin-1 (ET) in the pathophysiology of portal hypertension, we measured the plasma levels of ET in venous and portal blood of 37 patients with portal hypertension by means of enzyme immunoassay. The ET levels in venous blood (ETv) in patients with liver cirrho...

Full description

Saved in:
Bibliographic Details
Published inKanzo Vol. 41; no. 12; pp. 789 - 798
Main Authors KURODA, Masahito, KOJIMA, Toshihiko, KAISE, Shunji, OHIRA, Hiromasa, OBARA, Katsutoshi, TAKAGI, Tohru, KASUKAWA, Reiji
Format Journal Article
LanguageJapanese
Published The Japan Society of Hepatology 2000
Online AccessGet full text
ISSN0451-4203
1881-3593
DOI10.2957/kanzo.41.789

Cover

Abstract To investigate the significance of endothelin-1 (ET) in the pathophysiology of portal hypertension, we measured the plasma levels of ET in venous and portal blood of 37 patients with portal hypertension by means of enzyme immunoassay. The ET levels in venous blood (ETv) in patients with liver cirrhosis (LC, n=16), idiopathic portal hypertension (IPH, n=13) and primary biliary cirrhosis (PBC, n=8) were higher than those in healthy subjects. The ET levels in portal blood (ETp) in patients with IPH were significantly lower than those in patients with LC and PBC. No correlation between the levels of ETv or ETp and values of portal vein pressure (PVP) was noted in any kinds of diseases. ETp values correlated with total bilirubin values in LC patients, whereas ETv and ETp values correlated with indocyanine green dye retention rate at 15 minutes values in PBC patients. After endoscopic injection sclerotherapy (EIS) of esophagogastric varices, both ETp levels and PVP values were decreased in 4 of 6 LC patients, whereas both ETp levels and PVP values were increased in 2 of 3 PBC patients. These results suggest that ETp might play some roles in the pathophysiology of portal hypertension.
AbstractList To investigate the significance of endothelin-1 (ET) in the pathophysiology of portal hypertension, we measured the plasma levels of ET in venous and portal blood of 37 patients with portal hypertension by means of enzyme immunoassay. The ET levels in venous blood (ETv) in patients with liver cirrhosis (LC, n=16), idiopathic portal hypertension (IPH, n=13) and primary biliary cirrhosis (PBC, n=8) were higher than those in healthy subjects. The ET levels in portal blood (ETp) in patients with IPH were significantly lower than those in patients with LC and PBC. No correlation between the levels of ETv or ETp and values of portal vein pressure (PVP) was noted in any kinds of diseases. ETp values correlated with total bilirubin values in LC patients, whereas ETv and ETp values correlated with indocyanine green dye retention rate at 15 minutes values in PBC patients. After endoscopic injection sclerotherapy (EIS) of esophagogastric varices, both ETp levels and PVP values were decreased in 4 of 6 LC patients, whereas both ETp levels and PVP values were increased in 2 of 3 PBC patients. These results suggest that ETp might play some roles in the pathophysiology of portal hypertension.
Author OHIRA, Hiromasa
KAISE, Shunji
KOJIMA, Toshihiko
OBARA, Katsutoshi
TAKAGI, Tohru
KASUKAWA, Reiji
KURODA, Masahito
Author_xml – sequence: 1
  fullname: KURODA, Masahito
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: KOJIMA, Toshihiko
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: KAISE, Shunji
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: OHIRA, Hiromasa
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: OBARA, Katsutoshi
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: TAKAGI, Tohru
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
– sequence: 1
  fullname: KASUKAWA, Reiji
  organization: Department of Internal Medicine II, Fukushima Medical University School of Medicine
BookMark eNo9kMtOwzAQRS1UJErpjg_wB5DiRxzbS1RBQarEpqwjx7EbQ2pHtgGVrye0pZuZke45s7jXYOKDNwDcYrQgkvH7D-V_wqLECy7kBZhiIXBBmaQTMEUlw0VJEL0C85RcgxCpOJKSTMGw6QzUvfNOqx4mt_XOjqfXBgYLh16lnYLGtyF3ZqQKDJ2HX8aHzwSVb-EQYh7Fpg-hPRgqO-Nzgt8ud_9ptx9MzMYnF_wNuLSqT2Z-2jPw9vS4WT4X69fVy_JhXWhCqlxYwUpJkECaScQlZ8qylrSoUahBgmLRaI6t4IwJg6msOGENp1gapgQpraQzcHf8q2NIKRpbD9HtVNzXGNV_hdWHwuoS12NhI7464u8pq605wypmp3tzhLGs0J-AyWmO5pnQnYq18fQX0_Z7Sg
ContentType Journal Article
Copyright The Japan Society of Hepatology
Copyright_xml – notice: The Japan Society of Hepatology
DBID AAYXX
CITATION
DOI 10.2957/kanzo.41.789
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 798
ExternalDocumentID 10_2957_kanzo_41_789
article_kanzo1960_41_12_41_12_789_article_char_en
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
P2P
RJT
2WC
AAYXX
CITATION
OK1
ID FETCH-LOGICAL-c226t-f85492080c5907975af5d2d0ba0b08318bc71f87558e1396725b7319e5a824f93
ISSN 0451-4203
IngestDate Tue Jul 01 01:58:57 EDT 2025
Wed Sep 03 06:08:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c226t-f85492080c5907975af5d2d0ba0b08318bc71f87558e1396725b7319e5a824f93
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo1960/41/12/41_12_789/_article/-char/en
PageCount 10
ParticipantIDs crossref_primary_10_2957_kanzo_41_789
jstage_primary_article_kanzo1960_41_12_41_12_789_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2000-00-00
PublicationDateYYYYMMDD 2000-01-01
PublicationDate_xml – year: 2000
  text: 2000-00-00
PublicationDecade 2000
PublicationTitle Kanzo
PublicationTitleAlternate Kanzo
PublicationYear 2000
Publisher The Japan Society of Hepatology
Publisher_xml – name: The Japan Society of Hepatology
References 11) 小原勝敏, 正木盛夫, 坂本弘明, 他: 食道・胃静脈瘤硬化療法におけるEO単独およびEO・AS併用法からみた予後の検討. Gastroenterol. Endosc. 29: 2232-2236, 1987
16) Rieder H, Ramadori G, Meyer KH,: Sinusoidal endothelial liver cells in vitro release endothelin-Augmentation by transforming growth factor β and kupffer cellconditioned media. Klin Wochenschr 69: 387-391, 1991
3) Luscher TF, Tanner FC: Endothelial regulation of vascular tone and growth. Am J Hypertens 6: 283-293, 1993
24) Namiki A, Hirata Y, Ishikawa M,: Endothelin-1 and endothelin-3 induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci 50: 677-682, 1992
7) Gandhi C. R, Stephenson K, Olson M. S,: Endothelin, a potent peptide agonist in the liver. J Biol Chem 265: 17432-17435, 1990
13) 成瀬光栄, 大隈一興, 成瀬清子, 他: 血中エンドセリンのラジオイムノアッセイに関する基礎的, 臨床的検討. エンドセリンー最新情報, 平田結喜緒, 柳沢正史編, 中外医学社, 東京, 1990, p171-174
19) 竹井謙之, 後藤守孝, 福井弘幸, 他: 肝微小循環-最近の話題-. 最新医学46: 73-80, 1991
27) Toyonaga A, Iwao T, Sumino M,: Portal pressure after prophylactic sclerotherapy in patients with high-risk varices. J Hepatol 21: 515-520, 1994
4) Moller S, Henriksen JH: Endothelins in chronic liver disease. Scand J Clin Lab Invest 56: 481-490, 1996
25) 正木盛夫, 三橋彦也, 近藤祐一郎, 他: 食道静脈瘤栓塞剤 (Ethanolamine oleate; EO) の作用機序に関する研究-内皮細胞障害作用. 日消誌81: 1491, 1984
18) Bluhm RE, Frazer MG, Vore M,: Endothelin 1 and 3: Potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology 18: 961-968, 1993
14) Veglio F, Pinna G, Melchio R,: Plasma endothelin levels in cirrhotic subjects. J Hepatol 15: 85-87, 1992
26) 折笠和栄: 食道静脈瘤硬化剤 (Ethanolamine oleate, Aethoxysklerolおよび純エタノール) の血管内皮細胞障害機序に関する研究. 日消誌86: 2365-2372, 1989
2) Yanagisawa M, Kurihara H, Kimura S,: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
28) 平田結喜緒: エンドセリン拮抗薬の臨床応用の可能性. 呼と循44: 1009-1017, 1996
22) 中沼安二, 太田五六: 原発性胆汁性肝硬変と門脈圧亢進: その成因に関する組織計測学的研究と他の慢性肝疾患との対比. 肝臓20: 54-61, 1979
6) Isobe H, Satoh M, Sakai H,: Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 17: 227-230, 1993
8) Gondo K, Ueno T, Sakamoto M,: The endothelin-1 binding site in rat liver tissue: light-and electron-microscopic autoradiographic studies. Gastroenterology 104: 1745-1749, 1993
17) Pinzani M, Milani S, Defranco R,: Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110: 534-548, 1996
15) Uchihara M, Izumi N, Sato C,: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 16: 95-99, 1992
12) 小原勝敏, 入沢篤志, 小島俊彦, 他: 孤立性胃静脈瘤にはこれだ瞬間接着剤cyanoacrylate. 消化器内視鏡7: 43-53, 1995
23) 笠井保志, 原田明生, 高木弘: エンドトキシン門脈内注入による特発性門脈圧亢進症 (IPH) 類似肝病変の作製. 肝臓31: 86-92, 1990
1) Vane J: Control of the circulation by endothelial mediators. Int Arch Allergy Immunol 101: 333-345, 1993
9) Sakamoto M, Ueno T, Kin M,: Ito cell contraction in response to endothelin-1 and substance P. Hepatology 18: 978-983, 1993
10) Martinet JP, Legault L, Cernacek P,: Changes in plasma endothelin-1 and big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 25: 700-706, 1996
5) Asbert M, Gines A, Gines P,: Circulating levels of endothelin in cirrhosis. Gastroenterology 104: 1485-1491, 1993
20) 須田陽子: 原発性胆汁性肝硬変における食道静脈瘤の特異性に関する臨床的研究. 新潟医誌102: 344-352, 1988
21) Kew MC, Varma RR, Dos Santos HA,: Portal hypertension in primary biliary cirrhosis. Gut 12: 830-834, 1971
References_xml – reference: 6) Isobe H, Satoh M, Sakai H,: Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 17: 227-230, 1993
– reference: 13) 成瀬光栄, 大隈一興, 成瀬清子, 他: 血中エンドセリンのラジオイムノアッセイに関する基礎的, 臨床的検討. エンドセリンー最新情報, 平田結喜緒, 柳沢正史編, 中外医学社, 東京, 1990, p171-174
– reference: 2) Yanagisawa M, Kurihara H, Kimura S,: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
– reference: 24) Namiki A, Hirata Y, Ishikawa M,: Endothelin-1 and endothelin-3 induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci 50: 677-682, 1992
– reference: 11) 小原勝敏, 正木盛夫, 坂本弘明, 他: 食道・胃静脈瘤硬化療法におけるEO単独およびEO・AS併用法からみた予後の検討. Gastroenterol. Endosc. 29: 2232-2236, 1987
– reference: 18) Bluhm RE, Frazer MG, Vore M,: Endothelin 1 and 3: Potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology 18: 961-968, 1993
– reference: 4) Moller S, Henriksen JH: Endothelins in chronic liver disease. Scand J Clin Lab Invest 56: 481-490, 1996
– reference: 10) Martinet JP, Legault L, Cernacek P,: Changes in plasma endothelin-1 and big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 25: 700-706, 1996
– reference: 27) Toyonaga A, Iwao T, Sumino M,: Portal pressure after prophylactic sclerotherapy in patients with high-risk varices. J Hepatol 21: 515-520, 1994
– reference: 12) 小原勝敏, 入沢篤志, 小島俊彦, 他: 孤立性胃静脈瘤にはこれだ瞬間接着剤cyanoacrylate. 消化器内視鏡7: 43-53, 1995
– reference: 15) Uchihara M, Izumi N, Sato C,: Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 16: 95-99, 1992
– reference: 20) 須田陽子: 原発性胆汁性肝硬変における食道静脈瘤の特異性に関する臨床的研究. 新潟医誌102: 344-352, 1988
– reference: 8) Gondo K, Ueno T, Sakamoto M,: The endothelin-1 binding site in rat liver tissue: light-and electron-microscopic autoradiographic studies. Gastroenterology 104: 1745-1749, 1993
– reference: 21) Kew MC, Varma RR, Dos Santos HA,: Portal hypertension in primary biliary cirrhosis. Gut 12: 830-834, 1971
– reference: 5) Asbert M, Gines A, Gines P,: Circulating levels of endothelin in cirrhosis. Gastroenterology 104: 1485-1491, 1993
– reference: 23) 笠井保志, 原田明生, 高木弘: エンドトキシン門脈内注入による特発性門脈圧亢進症 (IPH) 類似肝病変の作製. 肝臓31: 86-92, 1990
– reference: 1) Vane J: Control of the circulation by endothelial mediators. Int Arch Allergy Immunol 101: 333-345, 1993
– reference: 19) 竹井謙之, 後藤守孝, 福井弘幸, 他: 肝微小循環-最近の話題-. 最新医学46: 73-80, 1991
– reference: 26) 折笠和栄: 食道静脈瘤硬化剤 (Ethanolamine oleate, Aethoxysklerolおよび純エタノール) の血管内皮細胞障害機序に関する研究. 日消誌86: 2365-2372, 1989
– reference: 3) Luscher TF, Tanner FC: Endothelial regulation of vascular tone and growth. Am J Hypertens 6: 283-293, 1993
– reference: 14) Veglio F, Pinna G, Melchio R,: Plasma endothelin levels in cirrhotic subjects. J Hepatol 15: 85-87, 1992
– reference: 25) 正木盛夫, 三橋彦也, 近藤祐一郎, 他: 食道静脈瘤栓塞剤 (Ethanolamine oleate; EO) の作用機序に関する研究-内皮細胞障害作用. 日消誌81: 1491, 1984
– reference: 9) Sakamoto M, Ueno T, Kin M,: Ito cell contraction in response to endothelin-1 and substance P. Hepatology 18: 978-983, 1993
– reference: 7) Gandhi C. R, Stephenson K, Olson M. S,: Endothelin, a potent peptide agonist in the liver. J Biol Chem 265: 17432-17435, 1990
– reference: 16) Rieder H, Ramadori G, Meyer KH,: Sinusoidal endothelial liver cells in vitro release endothelin-Augmentation by transforming growth factor β and kupffer cellconditioned media. Klin Wochenschr 69: 387-391, 1991
– reference: 22) 中沼安二, 太田五六: 原発性胆汁性肝硬変と門脈圧亢進: その成因に関する組織計測学的研究と他の慢性肝疾患との対比. 肝臓20: 54-61, 1979
– reference: 28) 平田結喜緒: エンドセリン拮抗薬の臨床応用の可能性. 呼と循44: 1009-1017, 1996
– reference: 17) Pinzani M, Milani S, Defranco R,: Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110: 534-548, 1996
SSID ssib002670992
ssib000940394
ssib002670224
ssib058493441
ssj0069113
ssib005879686
ssib002484534
Score 1.5171663
Snippet To investigate the significance of endothelin-1 (ET) in the pathophysiology of portal hypertension, we measured the plasma levels of ET in venous and portal...
SourceID crossref
jstage
SourceType Index Database
Publisher
StartPage 789
Title The clinical significance of plasma endothelin-1 in venous and portal blood of patients with portal hypertension
URI https://www.jstage.jst.go.jp/article/kanzo1960/41/12/41_12_789/_article/-char/en
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Kanzo, 2000/12/25, Vol.41(12), pp.789-798
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKQIgXxFWMm_wATyglTuw4fqMgULtpINgm7a2KnXhNJ5KpTXngD_C3Ob4kdac9DF6iNvZJm5yvx99xzwWhN7mMK5UzFcUluKtUS7CDlYojVWqdcJUpUdoA2a_Z9JQenLGz0ehPELW06eRY_b42r-R_tArnQK8mS_YfNDtcFE7Aa9AvHEHDcLyxjrepjfV5Y-J-bA5Aa_tDr38W76qmNElWMCsiZnPjlyvKausDWOrtYtethKux6hPe_OgCHNWVDXP3CvRM9hBIZTuY628Hs6OJ1X27XtSL-mI7NJkd24jL48WmWdbDpu7HyY-JD-dYbzojNQxNZ25oWq9M9FKxszMRB6aLMvBMk9iZrsqZ1jwnUcpcP8Te9rqiVz3GksCSctdZyC_K3LWqvmrvE2GbFF-YOx5TMh6EwrLaV5a7IQgR3B8jP7fSc0rmIH0L3U44JyY29PB7wFMFjdPQD6Y5ZWnox3LDhXbei-DvapZzkW3r9AHpE6nloY4yZLDi2FCI_rG5DA3z7d6H97bDne4swX3oQw8tGzp5gO57NwZPHCYfotGyeITuHvlAjcfoEqCJe2jiEJq41dhBE4fQxHWDHTQxQBM78GELTSvhoYkNNPvREJpP0OmXzyefppFv7hEpYPxdpHNTGxD8FcVEzAVnhWZlUsayiKXpfpdLxYkGb5rlFXgpGU-Y5LBeVKzIE6pF-hTtNW1TPUNYioIC75SUKE01FzID0k00JbIkkpbJPnrbP7b5pavhMr9O-fvog3umwyz_y3azYK2KzUyS-COIDDNMjiSYpOc3_KgX6J6r6WD28l6ivW61qV4Bu-3ka4u8vwLuoLA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+clinical+significance+of+plasma+endothelin-1+in+venous+and+portal+blood+of+patients+with+portal+hypertension&rft.jtitle=Kanzo&rft.au=KOJIMA%2C+Toshihiko&rft.au=KAISE%2C+Shunji&rft.au=OBARA%2C+Katsutoshi&rft.au=OHIRA%2C+Hiromasa&rft.date=2000&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=41&rft.issue=12&rft.spage=789&rft.epage=798&rft_id=info:doi/10.2957%2Fkanzo.41.789&rft.externalDBID=n%2Fa&rft.externalDocID=10_2957_kanzo_41_789
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon